Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3000 Coliseum Dr
Suite 104
Hampton, VA 23666Phone+1 757-827-9400Fax+1 757-827-9320- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
- Temple University HospitalResidency, Internal Medicine, 1999 - 2002
- The University of Toledo College of MedicineClass of 1999
Certifications & Licensure
- VA State Medical License 2006 - 2026
- NY State Medical License 2003 - 2007
- NJ State Medical License 2002 - 2003
- PA State Medical License 2000 - 2002
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) Start of enrollment: 2008 May 01
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma Start of enrollment: 2010 Dec 01
- First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.Channing J Paller, Pedro C Barata, Justin Lorentz, Leonard J Appleman, Andrew J Armstrong, Tiffani A DeMarco, Robert Dreicer, Jo Ann B Elrod, Mark Fleming, Christopher...> ;The Prostate. 2024 Feb 1
- Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.Susan F Slovin, Karen Knudsen, Susan Halabi, Renee de Leeuw, Ayesha Shafi, Praneet Kang, Steven Wolf, Bin Luo, Anuradha Gopalan, Tracy Curley, Mark Fleming, Ana Molina...> ;Journal of Clinical Oncology. 2023 Nov 10
- Reply by Authors.Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski, Daniel Saltzstein, Mark T Fleming, Albert Chau, Phillip Davis, Brian F ...> ;The Journal of Urology. 2023 Aug 1
- Join now to see all
Journal Articles
- Phase 1 Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate CancerMark T Fleming, Luke T Nordquist, William R Berry, Clinical Cancer Research
Press Mentions
- AUA 2022: Late-Breaking Plenary HighlightsJuly 27th, 2022
- Creating an Inclusive Environment in Your Oncology Practice with Mark Fleming, MDJuly 11th, 2022
- Oncologists “In a Quandary” over Lack of Second-Line Guidance in Bladder CancerFebruary 21st, 2024
Professional Memberships
- Member
Hospital Affiliations
- Chesapeake Regional Medical CenterChesapeake, Virginia
- Riverside Regional Medical CenterNewport News, Virginia
- Sentara CarePlex HospitalHampton, Virginia
- Sentara Norfolk General HospitalNorfolk, Virginia
- Sentara Virginia Beach General HospitalVirginia Beach, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: